KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Capital Leases (2017 - 2025)

Astrana Health's Capital Leases history spans 9 years, with the latest figure at $543000.0 for Q1 2025.

  • For Q1 2025, Capital Leases fell 46.5% year-over-year to $543000.0; the TTM value through Mar 2025 reached $543000.0, down 46.5%, while the annual FY2024 figure was $607000.0, 41.24% down from the prior year.
  • Capital Leases for Q1 2025 was $543000.0 at Astrana Health, down from $607000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $1.3 million in Q4 2022 and bottomed at $221000.0 in Q3 2021.
  • The 5-year median for Capital Leases is $973000.0 (2021), against an average of $845647.1.
  • The largest annual shift saw Capital Leases soared 323.1% in 2022 before it crashed 46.5% in 2025.
  • A 5-year view of Capital Leases shows it stood at $973000.0 in 2021, then soared by 31.04% to $1.3 million in 2022, then dropped by 18.98% to $1.0 million in 2023, then tumbled by 41.24% to $607000.0 in 2024, then dropped by 10.54% to $543000.0 in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Capital Leases are $543000.0 (Q1 2025), $607000.0 (Q4 2024), and $743000.0 (Q3 2024).